Drug Type Small molecule drug |
Synonyms fucoidan |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Start Date04 Mar 2024 |
Sponsor / Collaborator |
Start Date16 Jun 2023 |
Sponsor / Collaborator |
Start Date01 Oct 2022 |
Sponsor / Collaborator |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Helicobacter pylori infection | Phase 2 | CN | 01 Oct 2022 |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
Not Applicable | 88 | fucodin | hvovzlgfsm(honthfydpu): P-Value = 0.007 View more | Positive | 24 Jan 2023 | ||
placebo | |||||||
Not Applicable | - | Low-Molecular-Weight Fucoidan | doxokdfitu(dpiptshney) = imiyfmpybl zyloerddtl (dqxmdmikft ) | Positive | 21 Apr 2017 |